Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What the lab can and cannot do: clinical interpretation of drug testing results
Bhushan Kapur, Katarina Aleksa
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 8, pp. 548-585
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Internal standard strategies for amino acid and polyamine quantification in rat urine and plasma via chemical derivatization-assisted LC–MS/MS
Mingyu Kim, Sang-Hoon Song, Suji Kim, et al.
Microchemical Journal (2025), pp. 113063-113063
Open Access
Density Functional Theory–Spectroscopy Integrated Identification Method Encompassing Experimental and Theoretical Analyses for Designer Drug Stimulants
Keunhong Jeong, Youngjoon Jeon, Sein Min, et al.
Advanced Intelligent Systems (2025)
Open Access
Advances, Nuances, and Future Directions in Neonatal Toxicology Testing
Clive H. Gold, Stephanie L. Bourque, Katharine Wagner, et al.
NeoReviews (2025) Vol. 26, Iss. 4, pp. e233-e246
Closed Access
A multicomponent LC-MS/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine
Joar Guterstam, Christoffer Tavic, Miguel Barosso, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 243, pp. 116075-116075
Open Access | Times Cited: 4
Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code
Ann Kearns Davoren, Kelly L. Rulison, Jeff Milroy, et al.
Sports Medicine - Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals
Christine L.H. Snozek, Claire I. Yee, Janetta Bryksin, et al.
American Journal of Clinical Pathology (2024)
Closed Access | Times Cited: 2
Honeycomb resin-based spin-column solid-phase extraction for efficient determination of alectinib and its metabolite in human urine
Zihui Zhao, Pengfei Li, Yehong Han, et al.
Journal of Chromatography A (2023) Vol. 1690, pp. 463787-463787
Closed Access | Times Cited: 6
Evaluation of urine drug screen falsification of results among patients with opioid use disorder receiving treatment in a telehealth model of care
Rebekah Rollston, Barbara Burke, Scott G. Weiner, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 154, pp. 209151-209151
Closed Access | Times Cited: 4
The North American opioid epidemic: opportunities and challenges for clinical laboratories
Sarah Delaney, Danyel H. Tacker, Christine L.H. Snozek
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 5, pp. 309-331
Closed Access | Times Cited: 6
A rapid Dilute-and-Shoot LC-MS/MS method for quantifying THC-COOH and THC-COO(Gluc) in urine
Brandy Young, Y. Victoria Zhang
Journal of Chromatography B (2022) Vol. 1211, pp. 123495-123495
Closed Access | Times Cited: 6
A Review on the Impact of Cannabis in Society and the Analytical Methodologies for Cannabinoids
Matthew J. Vergne, L Reynolds, Alexus Brown, et al.
Psychoactives (2023) Vol. 2, Iss. 1, pp. 37-51
Open Access | Times Cited: 3
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 5, pp. 453-465
Closed Access | Times Cited: 3
Promising approaches and kinetic prospects of the microbial degradation of pharmaceutical contaminants
S. Karishma, P.R. Yaashikaa, P. Senthil Kumar, et al.
Environmental Science Advances (2023) Vol. 2, Iss. 11, pp. 1488-1504
Open Access | Times Cited: 3
Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing
Nazila Jamshidi, Akshay Athavale, Christopher Tremonti, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 7, pp. 1938-1947
Open Access | Times Cited: 5
Exploring Enzymatic Hydrolysis of Urine Samples for Investigation of Drugs Associated with Drug-Facilitated Sexual Assault
Kathrine Skov, Sys Stybe Johansen, Kristían Línnet, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 13-13
Open Access | Times Cited: 2
Factors Determining Plasticity of Responses to Drugs
Michael J. Parnham, Jennifer Kricker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2068-2068
Open Access | Times Cited: 4
Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction
Udo Bonnet, Thorsten Borda, Norbert Scherbaum, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 670-676
Open Access | Times Cited: 5
On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents
Laura Mercolini, Michele Protti, Roberto Mandrioli
International Clinical Psychopharmacology (2022)
Closed Access | Times Cited: 3
Alcohol: Postmortem Findings - Acute and Chronic
Alan Wayne Jones
Elsevier eBooks (2024), pp. 165-194
Closed Access
Therapeutic drug monitoring using alternative specimens
Kenichi Tamama
Therapeutic Drug Monitoring (2024), pp. 91-106
Closed Access
Screening for Drug Use and Misuse
Shinjini Choudhury, Abhishek Ghosh
Springer eBooks (2024), pp. 1-26
Closed Access
Evaluating Bias and Racism in a Risk-Factor–Based Drug Testing Policy in the Labor and Delivery Department
Arienne Malekmadani, L. Puglisi, Roman Starikov, et al.
Deleted Journal (2024) Vol. 1, Iss. 4, pp. 044-044
Open Access
Urine as a matrix for new psychoactive substances (NPS) detection: Analytical challenges, methods, and considerations
Olga Lucía Zapata Marin, Sandra F. Fernández
Comprehensive analytical chemistry (2024)
Closed Access
Trending Urine Cocaine/BE Levels for Patient Advocacy: Case Report
Jillian Macklin, Cristiana Stefan, Tianna Costa, et al.
The Canadian Journal of Addiction (2024) Vol. 15, Iss. 4, pp. 42-45
Closed Access
Brain Drug Effect Detection on Impulsivity with Ensemble Bagged Trees Method
Ani Dijah Rahajoe, Arief Wibowo, Agussalim Agussalim, et al.
(2023), pp. 1-6
Closed Access
Page 1 - Next Page

Scroll to top